Background Pirfenidone has been shown to slow disease progression in patients with
idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive …

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has been defined as an acute,
clinically significant deterioration that develops within less than 1 month without obvious …

Rationale: Analyzing the molecular heterogeneity of different forms of organ fibrosis may
reveal common and specific factors and thus identify potential future therapeutic targets. …

The correspondence of cell state changes in diseased organs to peripheral protein signatures
is currently unknown. Here, we generated and integrated single‐cell transcriptomic and …

Background Anti-fibrotic drugs may interfere with wound-healing after major surgery, theoretically
preventing sufficient bronchial anastomosis formation after lung transplantation (LTx). …

Objectives To evaluate the effect of structured reporting of CT pulmonary angiography (CTPA)
studies on the content, clarity and clinical usefulness of radiology reports in acute …

The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2
antigens remains poorly understood. Conventional methods to detect antigen-…

Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF
requires considerable expertise and experience. Since the publication of the international IPF …

Background Fibrotic interstitial lung disease (ILD) is often associated with poor outcomes,
but has few predictors of progression. Daily home spirometry has been proposed to provide …

Physical activity limitations and cough are common in patients with interstitial lung disease (ILD),
potentially leading to reduced health-related quality of life. We aimed to compare …